BRAIN NEOPLASMS
Clinical trials for BRAIN NEOPLASMS explained in plain language.
Never miss a new study
Get alerted when new BRAIN NEOPLASMS trials appear
Sign up with your email to follow new studies for BRAIN NEOPLASMS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human test of Pfizer's brain cancer drug halted
Disease control TerminatedThis was an early-stage study to test the safety and initial effectiveness of a new drug, PF-07284890, for people with advanced cancers that have a specific genetic change called a BRAF V600 mutation. The trial included patients with cancers like melanoma and lung cancer, some of…
Matched conditions: BRAIN NEOPLASMS
Phase: PHASE1 • Sponsor: Pfizer • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Early cancer imaging study halted after limited testing
Diagnosis TerminatedThis was an early, first-in-human study to test a new radioactive imaging agent called [68Ga]-FF58. The goal was to see if it could safely and effectively highlight specific aggressive cancers (like glioblastoma and pancreatic cancer) during PET scans. The study was terminated ea…
Matched conditions: BRAIN NEOPLASMS
Phase: EARLY_PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Diagnosis
Last updated Mar 30, 2026 14:35 UTC